Download Date:

Papers in Refereed Journals
1. Raz R, Akerman S, Keness Y, Colodner R, Reichman N, Miron D, Flatau E.
The incidence of pneumococcal carrier state in children in Northern Israel and
their susceptibility to penicillin. Israel Journal of Medical Sciences. 1993;
vol.29-5: 308-310.
2. Raz R, Elhanan G, Colodner R, Reiss S, Schwartzman P, Tabenkin H, and
Leshem Y. Penicillin V twice daily vs. four times daily in the treatment of
streptococcal pharyngitis. Infectious Diseases in Clinical Practice. 1995; 1:
50-54.
3. Cohen RO, Colodner R, Ziv G, Keness Y. Isolation and antimicrobial
susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy
cows with retained fetal membranes and postparturient endometritis. Journal
of Veterinary Medicine. 1996; B43, 193-199.
4. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of
nasal mupirocin in the prevention of recurrent staphylococcal nasal
colonization and skin infection. Archives of Internal Medicine. 1996; 156:
1109-1112.
5. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yoghurt
containing lactobacillus acidophilus compared to pasteurized yoghurt as
prophylaxis for recurrent candidal vaginitis and/or bacterial vaginosis.
Archives of Family Medicine. 1996; 5: 593:596.
6. Sakran W, Raz R, Colodner R, Keness Y. Isolated susceptibility of
Streptococcus pyogenes to three macrolides. Harefuah. 1997; 9: 365-366.
7. Raz R, Soboh S, Abu Much Z, Keness Y, Rafael C, Colodner R.
Pneumococcal carriage in geriatric institute residents. Infectious Diseases in
Clinical Practice - 1999; 8: 291-293.
8. Sakran W, Raz R, Levi Y, Colodner R, Koren A. Campylobacter bacteremia
and pneumonia in splenectomized patients. European Journal of Clinical
Microbiology and Infectious Diseases. 1999 Jul;18(7):496-8.
9. Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S,
Colodner R, Cameron D, Wykstra D, Swerdlow D, Farmer JJ. Clinical,
epidemiological and microbiological features of a Vibrio vulnificus biogroup 3
causing outbreaks of wound infection and bacteraemia in Israel. Lancet. 1999
Oct 23;354(9188):1421-4.
10. Miron D, Colodner R, Keness Y. Age-related seroprevalence of
Cryptosporidium in Northern Israel. Israel Medical Association Journal
2000;2:343:345.
11. Colodner R, Chazan B, Kopelowitz J, Keness Y, Raz R. An anusual portal of
entry of Vibrio vulnificus – evidence of its prolonged survival on the skin.
Clinical Infectious Diseases. 2002 Mar 1;34(5):714-5
12. Colodner R, Keness Y. Evaluation of Dipstreak containing CNA-MacConkey
agar, a new bedside urine culture device. Israel Medical Association Journal
2000 Jul;2(7):563-5.
13. Rakover Y, Smuskovitz A, Colodner R, Keness Y, Rosen G. Duration of the
antibacterial effectiveness of gentamicin ear drops in external otitis. Journal of
Laryngology and Otology, November 2000, 114:827-829.
14. Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R, Kandula
D, Sobel JD. Urinary tract infection among women aged 40 to 65. Behavioral
and sexual risk factors. Journal of Clinical Epidemiology 2001 Jul;54(7):7108.
15. Colodner R, Keness Y, Chazan B, Raz R. Antimicrobial susceptibility of
community-acquired uropathogens in Northern Israel. International Journal of
Antimicrobial Agents, 2001; 18 (2):189-192.
16. Salim R, Ben-Shlomo I, Colodner R, Keness Y, Shalev E. Bacterial
colonization of the uterine cervix and success rate in assisted reproduction:
results of a prospective survey. Human Reproduction. 2002 Feb;17(2):337-40.
17. Marrs CF, Zhang L, Tallman P, Manning S, Somsel P, Raz R, Colodner R,
Jantunen ME, Siitonen A, Saxen H, Foxman B. Variations in ten putative
uropathogen virulence genes among urinary, fecal and periurethral
Escherichia coli. Journal of Medical Microbiology. 2002 Feb;51(2):138-42.
18. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I,
Stamm W. Empiric Use of Trimethoprim-Sulfamethoxazole (TMP-SMX) in
the Treatment of Women with Uncomplicated Urinary Tract Infections, in a
Geographical Area with a High Prevalence of TMP-SMX-Resistant
Uropathogens. Clinical Infectious Diseases 2002 May 1;34(9):1165-9.
19. Genizi J, Miron D, Colodner R, Lumilsky D, Bykov S, Horowitz Y.
Salmonella sacroiliitis and bacteremia in a child. Harefuah. 2002
Aug;141(8):685-8.
20. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin
as a marker of acute pyelonephritis in infants and children. Pediatric
Nephrology 2002; 17(6): 409-412.
21. Sakran W, Miron D, Halevy R, Colodner R, Smolkin V, Koren A.
Community acquired urinary tract infection among hospitalized children in
northern Israel: pathogens, susceptibility patterns and urinary tract anomalies.
Harefuah 2003 Apr;142(4):249-52.
2
22. Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, Stamm
W. Effectiveness of estriol containing vaginal pessaries and nitrofurantoin
macrocrystal therapy in the prevention of recurrent urinary tract infection in
postmenopausal women. Clinical Infectious Diseases. 2003 Jun
1;36(11):1362-8.
23. Colodner R, Sakran W, Miron D, Teitler N, Khavalevsky E, Kopelowitz J.
Listeria monocytogenes cross-contamination in a nursery. In press. American
Journal of Infection Control 2003;31(5):322-4.
24. Miron D, Lev A, Colodner R, Merzel Y. Compartment syndrome of the calf
as the initial manifestation of Vibrio Vulnificus associated severe infection in
a child with congenital spherocytosis. The Pediatric Infectious Disease
Journal 2003; 22(7):666-8.
25. Saliba WR, Goldstein LH, Raz R, Mader R, Colodner R, Elias MS. Subacute
necrotizing fasciitis caused by gas-producing Staphylococcus aureus.
European Journal of Clinical Microbiology and Infectious Diseases. 2003
Oct; 22(10): 612-4.
26. Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R.
Staphylococcus aureus carrier state among elderly residents in a long-term
care facility. Journal of the American Medical Directors Association
2003;4(3):125-7.
27. Chazan B, Shaabi M, Bishara E, Colodner R, Raz R. Clinical predictors of
streptococcal pharingitis in adults. The Israel Medical Association Journal.
June 2003;5:413-5.
28. Raz R, Sakran W, Chazan B, Colodner R, Kunin C. Long-term follow-up of
women hospitalized for acute pyelonephritis. Clinical Infectious Diseases.
2003 Oct 15;37(8):1014-20.
29. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by oral
administered Lactobacillus rhamnosus-GG (LGG). The Israel Medical
Association Journal. Nov 2003;5:767-9.
30. Colodner R, Raz R, Meir I, Lazarovich Z, Lerner L, Kopelowitz J, Keness Y,
Sakran W, Ken-Dror S, Bisharat N. Identification of the new emerging
pathogen Vibrio vulnificus biotype 3 using commercially-available phenotypic
methods. Journal of Clinical Microbiology. 2004;42(9):4137-4140.
31. Sakran W, Valinsky L, Koren A, Bor N, Yishay R, Colodner R. Early onset
of neonatal Streptococcus pneumoniae bacteremia and septic arthritis. Clinical
Pediatrics. 2004;43(6)579-81.
32. Colodner R, Rock W, Chazan B, Keller N, Guy N, Raz R. Risk factors for the
development of extended-spectrum beta-lactamases in non-hospitalized
patients. European Journal of Clinical Microbiology and Infectious Diseases.
March 2004;23(3):163-7.
3
33. Sakran W, Raz R, Chazan B, Koren A, Yishai R, Colodner R. Susceptibility
of Streptococcus pyogenes to two macrolides in Northern Israel. International
Journal of Antimicrobial Agents. 2004; 23(5):517-519.
34. Sakran W, Mazzawi S, Merzel Y, Colodner R. Streptococcal necrotizing
fasciitis with toxic shock syndrome following cervical adenitis. International
Journal of Pediatric Otorhinolaringology. Int J Pediatr Otorhinolaryngol.
2004 Sep;68(9):1209-13.
35. Colodner R, Raz R, Chazan B, Sakran W. Susceptibility pattern of ESBLproducing bacteria isolated from inpatients to five antimicrobial drugs in a
community hospital in northern Israel. International Journal of Antimicrobial
Agents. 2004; 24(4):409-410
36. Miron D, Torem M, Merom R, Colodner R. Azithromycin as an Alternative to
Nalidixic Acid for Therapy of Childhood Shigellosis. The Pediatric Infectious
Disease Journal. 2004 Apr; 23(4):367-8
37. Chazan B, Colodner R, Polacheck Y, Shoufani A, Rozenman D, Raz R.
Cutaneous infection by Cylindrocarpon lichenicola in an immunocompetent
patient. Journal of Travel Medicine. 2004 Sep-Oct;11(5):331-2.
38. Chazan B, Raz R, Sakran W, Colodner R. Improved antimicrobial
susceptibility of community-acquired uropathogens in northern Israel (19951999-2002). Int J Antimicrob Agents. 2004 Jul;24(1):89-92.
39. Johnson JR, Kuskowski MA, O’Bryan TT, Colodner R, Raz R. Virulence
genotype and phylogenetic origin in relation to antibiotic resistance profile
among Escherichia coli isolates from Israeli women with acute uncomplicated
cystitis. Antimicrobial Agents and Chemotherapy. 2005 Jan;49(1):26-31.
40. Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prere MF, Picard B,
Colodner R, Raz R and the Trans-Global Initiative for Antimicrobial
Resistance Analysis (TIARA) Investigators. Global Distribution and
Characteristics of Escherichia coli Clonal Group A. Emerging Infectious
Diseases. 2005 Jan;11(1):141-5.
41. Colodner R, Raz R. Extended-spectrum beta-lactamases: the end of
cephalosporins? Israel Medical Association Journal. 2005; 7:336-338
42. Chen Y, Colodner R, Chazan B, Raz R. Pharyngotonsillitis due to
Arcanobacterium haemolyticum in Northern Israel. Israel Medical Association
Journal. 2005 Apr;7:236-237.
43. Sakran W, Makary H, Colodner R, Ashkenazi D, Rakover Y, Halevy R,
Koren A. Acute otitis media in infants less than 12 weeks of age: clinical
presentation, etiology and concomitant diseases. International Journal of
Pediatric Otorhinolaringology. Accepted for publication August 2005.
4
44. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical
microbiologists and infection control specialists. American Journal of
Infection
Control. 2005;33(2):104-107.
45. Raz R, Colodner R, Kunin CM. Who are you – Staphylococcus
saprophyticus? Clinical Infectious Diseases. 2005. 40(6):896-8.
46. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous
conversion to quinolone and fluoroquinolone resistance among wild-type
Escherichia coli isolates in relation to phylogenetic background and virulence
genotype. Antimicrobial Agents and Chemotherapy. 2005; 49:4739-44.
47. Miron D, Horowitz Y, Lumelsky D, Hanania S, Colodner R. Dual pulmonary
infection with Candida dubliniensis and Aspergillus fumigatus in a child with
chronic granulomatous disease. Journal of Infection. 2005;50(1):72-5.
48. Raz R, Ben-Israel Y, Gronich D, Granot E, Colodner R, Visotzky I.
Usefulness of blood cultures in the management of febrile patients in longterm care facilities. European Journal of Clinical Microbiology and Infectious
Diseases. 2005 Nov;24(11):745-8.
49. Colodner R, Reznik B, Gal V, Yamazaki H, Hanaki H, Kubo R. Evaluation of
a novel kit – Cica-Beta Test I – for the rapid detection of extended-spectrum
beta-lactamases. European Journal of Clinical Microbiology and Infectious
Diseases. 2006;25(1):49-51.
50. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood
cultures necessary in the management of women with complicated
pyelonephritis? Journal of Infection. 2006;53(4):235-40.
51. Colodner R, Eliasberg T, Chazan B, Raz R. Clinical significance of
bacteriuria with low colony count of Enterococcus spp. European Journal of
Clinical Microbiology and Infectious Diseases. (2006) 25:238-241.
52. Turgeman Y, Levahar P, Lavi I, Shneor A, Colodner R, Samra Z, Bloch L,
Rosenfeld T. Adult calcific aortic stenosis and Chlamydia pneumoniae: the
role of Chlamydia infection in valvular calcification. The Israel Medical
Association Journal. 2006 Jul;8(7):464-8.
53. Colodner R, Ken-Dror S, Kavenshtock B, Chazan B, Raz R. Epidemiology
and clinical characteristics of patients with Staphylococcus saprophyticus
bacteriuria in Israel. Infection. 2006 Oct;34(5):278-281.
54. Nachum Z, Colodner R, Salim R, Gabarin D, Batino S, Shalev E. Probiotic
yogurt for the prevention of bacterial vaginosis recurrence in pregnant women
at risk of preterm labor. American Journal of Obstetrics and Gynecology.
2006;193(6): S192.
55. Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch
T, Bardenstein R, Schwartz-Harari O, Carmeli Y. First national surveillance of
5
susceptibility of extended-spectrum beta-lactamase-producing Escherichia
coli and Klebsiella spp to antimicrobials in Israel. Diagnostic Microbiology
and Infectious Diseases. 2007;57(2):201-205.
56. Chazan B, Kopelman D, Katz Z, Kniznik D, Chen Y, Colodner R, Raz R.
Fournier’s gangrene (FG) as the initial presentation of HIV infection.
International Journal of Infectious Diseases. 2007 Mar;11(2):184-185.
57. Rock W, Colodner R, Chazan B, Elias M, Raz R. Ten years surveillance of
antimicrobial susceptibility of community-acquired Escherichia coli and other
uropathogens in northern Israel (1995-2005). Israel Medical Association
Journal. 2007:9:803-805.
58. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for communityacquired urinary tract infection due to quinolone-resistant Escherichia coli.
Infection. 2008 Jan 12; Epub ahead of print.
59. Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and
pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis: a
case report. Israel Medical Association Journal. 2008 Feb;10(2):164-5.
60. Davidovich T, Rimbroth S, Hazan B, Colodner R, Markel A. Recurrent
septicemia and osteomyelitis caused by Pasteurella multocida in a patient with
chronic lymphativ leukemia. Israel Medical Association Journal. 2008
(10):653-654.
61. Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospitalacquired candiduria: comparison of prevalence and clinical characteristics.
European Journal of Clinical Microbiology and Infectious Diseases. 2008;
27(4):301-305.
62. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella zoster virus in
health care workers in northern Israel: seroprevalence and predictive value of
history of varicella infection. Am J Infect Control. 2008 Aug;36(6):436-8.
63. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in
Health Care Workers in Northern Israel: Seroprevalence and Predictive Value
of History of Varicella Infection. Accepted for publication at: American
Journal of Infection Control, 2008;36(6):436-8.
64. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in
Health Care Workers in Northern Israel: Seroprevalence and Predictive Value
of History of Varicella Infection. Accepted for publication at: American
Journal of Infection Control, 2008;36(6):436-8.
65. Galayduyk N, Colodner R, Chazan B, Flatau E, Lavi I, Raz R. Adherence to
guidelines on empiric use of antibiotics in the emergency room. Infection.
2008; 36(5):408-14.
6
66. Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S.
Ertapenem resistance among extended spectrum beta-lactamases producing
Klebsiella pneumoniae. Journal of Clinical Microbiology. 2009;47(4): p.969974.
67. Chazan B, Raz R, Teitler N, Nitzan O, Edelstein H, Colodner R.
Epidemiology and susceptibility to antimicrobials in community, hospital and
long-term-care-facility bacteremia in Northern Israel – a 6-Years Surveillance.
Israel Medical Association Journal. 2009; 9:592-597.
68. Colodner R, Nitzan O, Chazan B, Edelstein H, Raz R. Mannose-binding
lectin in pre-menopausal womed with recurrent urinary tract infections.
Clinical Microbiology and Infection. 2009 Nov 2. [Epub ahead of print]
7